China Isotope & Radiation Corp
HKEX:1763
P/FCFE
Price to FCFE
Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | P/FCFE | ||||
---|---|---|---|---|---|
CN |
C
|
China Isotope & Radiation Corp
HKEX:1763
|
3.5B HKD | 23.7 | |
JP |
Hoya Corp
TSE:7741
|
6.4T JPY | 40.3 | ||
CH |
Alcon AG
SIX:ALC
|
35.7B CHF | 121.3 | ||
DK |
Coloplast A/S
CSE:COLO B
|
193.7B DKK | 70.5 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
23.3B USD | 38.1 | ||
US |
Cooper Companies Inc
NYSE:COO
|
17.8B USD | 76.3 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
14.2T KRW | -117.3 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
56.8B CNY | 51.8 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 38.9 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.4B USD | 23.3 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.2B USD | 3.3 |
P/FCFE Forward Multiples
Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.